TickerGuard
Buy Day today: Neutral (54) Mixed market breadth · no major macro event
NGNE

Neurogene Inc

Healthcare · Biotechnology · —

25.50$ -3.9% vs. previous close Closing price · As of: Oct 6, 2026

Statements

Balance Sheet

All figures as the change versus the prior period, in percent. Periods without a positive comparison base stay empty.

Tick rows to compare them in a chart (up to 4)

Balance Sheet NGNE
Line item 2011 2012 2013 2014 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025
– -76.3% +2,409.3% -29.5% +173.6% +36.2% -28.5% -29.6% +89.4% +43.2% -51.8% +7.7% +103.7% +50.8% -14.0%
– -78.2% +2,663.4% -31.1% +90.3% +38.4% +5.2% -29.1% +86.1% +35.5% -62.0% +14.6% +136.5% +57.7% -14.0%
– -78.3% +2,605.6% -72.5% +165.2% -18.3% +61.1% +47.8% +86.0% +34.6% -63.4% +16.3% +80.7% -7.8% -24.0%
– -78.3% +2,746.6% -31.3% +90.5% +38.4% +4.9% -28.8% +86.0% +34.6% -63.4% +16.3% +140.4% +58.5% -13.9%
– -87.0% -2.1% +134.2% -51.1% – – – – – – +25.3% -39.4% +8.0% –
– – – – – – – – – – – -43.6% +38.8% – –
– -21.1% -26.7% – – – – – – -38.8% -63.1% – – – –
– +13.1% +409.8% -29.5% -6.7% +97.4% +17.8% -56.8% +7.9% +261.8% +901.7% -94.5% +243.6% -30.6% -6.5%
– -36.6% +579.9% +98.6% -7.9% +98.6% +15.1% -57.8% +2.5% +66.3% +37.6% -38.7% +245.4% -34.0% +8.3%
– – – – – – – – – +14.6% +158.6% -61.7% +310.5% +4.1% +2.2%
– -40.6% +218.1% +22.4% – – – – +128.5% -17.5% +325.5% -88.9% +315.4% -48.5% +46.2%
– -89.8% +5,767.6% -29.5% +199.9% +33.4% -31.6% -26.5% +95.0% +35.0% -148.0% – +88.6% +66.8% -14.7%
– – – – – – – – – – – – – – –
– +0.0% +0.0% -13.7% +45.8% +49.5% +24.1% +0.3% +14.9% +91.7% +6.2% -76.7% +0.0% +37.0% +20.5%

Data as of: October 6, 2026 · Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q)

Note: pure fact-based analysis, not investment advice and not a solicitation to buy or sell. All figures without guarantee.

Was this page helpful to you?